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httpcense.Abstract Background: The differentiation between complicated parapneumonic effusions (CPPE)
or empyema, which require chest tube drainage, and uncomplicated parapneumonic effusions
(UCPPE), which respond to antibiotic therapy alone, is sometimes unclear. Delay in diagnosis
results in substantial delay in the commencement of treatment and may contribute to the high mor-
tality of this infection.
The aim of the study: Evaluation of the utility of soluble triggering receptor expression on mye-
loid cells-1 (sTREM-1) as an early marker in the diagnosis and management of complicated para-
pneumonic effusions and empyema.
Patients and methods: This study included 58 patients who were diagnosed as having PPE and
admitted to the Chest Department, Zagazig University Hospitals during the period from March
2012 to March 2013. Patients were diagnosed PPE if they had a pleural effusion and showed one
or more clinical manifestations typical of pneumonia, including acute febrile illness, sputum pro-
duction, chest pain, leukocytosis and inﬁltrate(s) on chest X-ray. They were divided into two
groups.
Group (1): Complicated parapneumonic effusion (22 patients), according to at least one of the
following criteria on pleural ﬂuid examination: macroscopic pus, presence of organisms on Gram-23595477.
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594 A.H.A. Ghoneim et al.stain or culture, ﬂuid pH < 7.2 with normal peripheral blood pH, or ﬂuid glucose concentrations
<40 mg/dL.
Group (2): Uncomplicated parapneumonic effusion (36 patients), according to the following cri-
teria: pleural effusion associated with a non purulent pleural ﬂuid, negative ﬂuid microbiological
studies; ﬂuid pH > 7.2 with normal peripheral blood pH and ﬂuid glucose >40 mg/dL.
Exclusion criteria: A history of pleural disease or any underlying disease that could potentially
cause pleural effusions, such as tuberculosis, malignancy, heart failure, systemic lupus erythemato-
sus and chronic renal failure, were excluded. Pleural ﬂuid samples were examined for level of
sTREM-1, pH, LDH and glucose. The sTREM-1 levels were expressed as pg/mL. Microbiological
studies included: Gram and Ziehl–Neelsen stains and cultures on conventional media for aerobic
and anaerobic micro-organisms in the pleural ﬂuid samples.
Results: The median sTREM-1 level in pleural ﬂuid was signiﬁcantly higher in the bacterial PPE
(688 ± 398 pg/mL) than in the non-bacterial PPE (45 ± 79 pg/mL). The cut-off value of pleural
ﬂuid sTREM-1 for diagnosis of bacterial PPE was 130 pg/mL with 93% sensitivity and 92% spec-
iﬁcity, while it was 7.237 for pleural ﬂuid pH with 91% sensitivity and 96% speciﬁcity and 640 mg/L
for pleural ﬂuid glucose with 92% sensitivity and 86% speciﬁcity and 800 IU/L for pleural ﬂuid
LDH with 81% sensitivity and 90% speciﬁcity.
In conclusion: Combination of classical criteria with pleural ﬂuid sTREM-1 could be useful in
discrimination between nonpurulent complicated and non complicated parapneumonic pleural effu-
sions and hence early pleural drainage in patients with complicated parapneumonic effusions which
may affect disease outcome.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Pleural effusion is a common clinical entity that occurs in a
great variety of diseases [1]. Various studies listing the etiolo-
gies of pleural effusions have reported that parapneumonic
effusions account for 11–40% of all pleural effusions [2].
Unfortunately, the differentiation between complicated para-
pneumonic effusions (CPPE) or empyema, which require chest
tube drainage, and uncomplicated parapneumonic effusions
(UCPPE), which respond to antibiotic therapy alone, is some-
times unclear [3].
Delay in diagnosis results in substantial delay in the com-
mencement of treatment and may contribute to the high mor-
tality of this infection. Treatment of all patients with suspected
pleural effusion with antibiotics while waiting for microbiolog-
ical results is not a good option since this practice increases
antibiotic resistance. Diagnosis and differential diagnosis of
parapneumonic effusions pose a great problem. Biochemical
parameters are often non-speciﬁc and Gram stain has a low
sensitivity. Pleural ﬂuid cultures, even though being speciﬁc,
may take days to reveal a positive culture and in 30–35% of
cases, the organism fails to be cultured [1].
Triggering receptor expressed on myeloid cell (TREM) pro-
teins are a family of cell surface receptors expressed broadly on
myeloid cells. The ﬁrst TREM identiﬁed (TREM-1) is a re-
cently-discovered cell surface molecule expressed by neutro-
phils and monocytes. TREM-1 is a 30-kDa glycoprotein
belonging to the immunoglobulin super family, and its expres-
sion is upregulated by various ligands for Toll-like receptors
(TLRs). The initial characterization of TREM-1 demonstrated
that TREM-1 expression is upregulated in response to lipo-
polysaccharide and other microbial products. TREM-1 acts
synergistically with receptors for pathogen-associated molecu-
lar patterns, including both TLRs and Nod-like receptors.
Activation of TREM-1 expressed on neutrophils and mono-
cytes by an agonistic monoclonal antibody has been shownto stimulate the expression of various proinﬂammatory cyto-
kines, chemokines, and cell surface molecules. TREM-1 exists
in both a membranous and a soluble form (soluble triggering
receptor expressed on myeloid cells-1 (sTREM-1) [4].
TREM-1 is shed by the membrane of activated phagocytes
after exposure to bacteria and fungi and, its soluble form,
sTREM-1 can be detected in the body ﬂuids [5]. sTREM-1 is
a diagnostic marker for sepsis and inﬂammation. It has been
described as a diagnostic marker with a high accuracy and sen-
sitivity in detecting microbial infections as underlying disease
in critically ill patients [6]. The levels of sTREM-1 have previ-
ously been investigated in plasma, bronchoalveolar lavage
ﬂuid and exhaled breath [7].
Few studies have investigated the clinical signiﬁcance of
sTREM-1 in pleural effusions and found that patients with
PPE or empyema exhibited the highest pleural ﬂuid concentra-
tions of this biomarker. However, there were discrepancies
regarding its discriminative properties as well as its optimal
cut-off point [8]. Taking into account that the management
of complicated pyogenic bacterial effusions may be delayed
using classic diagnostic procedures the aim of this work was
to evaluate the utility of sTREM 1 as an early marker in the
diagnosis and management of complicated parapneumonic
effusions and empyema.
Patients and methods
Patients
The study included 58 patients diagnosed PPE admitted to the
Chest Department, Zagazig University Hospital during the
period from March 2012 to March 2013. A written informed
consent was obtained from all patients. Patients were diag-
nosed as having PPE if they had a pleural effusion and showed
one or more clinical manifestations typical of pneumonia,
including acute febrile illness, sputum production, chest pain,
Diagnostic utility of soluble triggering receptor expression 595leukocytosis and inﬁltrate(s) on chest X-ray. Patients were di-
vided into two groups.Group (1):Complicated parapneumonic
effusion (22 patients), according to at least one of the following
criteria on pleural ﬂuid examination: macroscopic pus, presence
of organisms onGram-stain or culture, ﬂuid pH < 7.2with nor-
mal peripheral blood pH, or ﬂuid glucose concentrations
<40 mg/dL. Group (2):Noncomplicated parapneumonic effu-
sion (36 patients), according to the following criteria: pleural
effusion associated with a non purulent pleural ﬂuid, negative
ﬂuid microbiological studies; ﬂuid pH > 7.2 with normal
peripheral blood pH and ﬂuid glucose >40 mg/dL.
Exclusion criteria
A history of pleural disease or any underlying disease that
could potentially cause pleural effusions, such as tuberculosis,
malignancy, heart failure, systemic lupus erythematosus and
chronic renal failure, were excluded.
Methods
Diagnostic plural ﬂuid samples using standard thoracocentesis
technique were collected in heparinized tubes from each pa-
tient and subjected to:
Biochemical analysis
Biochemical measurements were carried out using aHitachi 919
automatic analyser (BoehrigerMannheim, GMbH,Mannheim,
Germany), using the method of Biuret for proteins, hexokinase
for glucose, and pyruvate-to-lactate reduction at 37 for LDH.
For determination of pH, pleural ﬂuid was collected directly
into a heparinized blood-gas syringe and wasmaintained anaer-
obically. The syringe containing the pleural ﬂuid was immedi-
ately placed on ice and transferred to the laboratory. Pleural-
ﬂuid pHwasmeasuredwithin 20 min after thoracocentesis using
a selective pH electrode (Chiron Diagnostics 860; Ciba Corning
Diagnostics Corp., Medﬁeld, MA, USA). For sTREM-1 deter-
minations the concentrations of sTREM-1 in pleural ﬂuid were
measured using ELISA kits according to the manufacturer’s
protocol (R&D Systems Inc., Minneapolis, MN, USA). The
sTREM-1 levels were expressed as pg/mL.
Microbiological studies
Gram and Ziehl–Neelsen stains were carried out and cultures
were performed on conventional media for aerobic and anaer-
obic micro-organisms (Phedebact Pneumococcus test; Boule
Diagnostics, Huddinge, Sweden). Total white blood cell counts
were carried out with a Coulter-s-Plus IV Counter Izasa,
Spain. To differentiate between leukocytes, the sample wasTable 1 Characteristics of the patients with complicated or uncom
CPPE (n= 22)
Age, years 63 ± 12
Males, n (%) 16 (72.7%)
Female, n (%) 6 (27.3%)
Comorbidities, n (%) 11 (50%)
Diabetes mellitus 5
COPD 5
Neuropsychiatric disease 1centrifuged (Cytospin 2, Shandon Southern Products Ltd,
UK) at 2000 rpm for 8 min, and the preparation obtained
was stained with May-Grunwald-Giemsa.
Statistical analysis
Statistical analysis was performed with SPSS version19 soft-
ware package (SPSS, Inc. Chicago). Categorical variables were
expressed as proportions, and continuous variables that were
or were not normally distributed were expressed as
means ± SD or medians (quartiles), respectively. The t-test
or Mann–Whitney test was used to compare means or medians
between different groups, for variables that were or were not
normally distributed, respectively. Receiver Operator Curves
(ROC) were designed to assess sensitivity, speciﬁcity, positive
and negative predictive values for the estimated parameters
to predict CPPE. For all analyses, a two-tailed P value
<0.05 was considered signiﬁcant.
Results
The study included 58 patients (41 males and 17 females), of
these, 22 had CPPE (16 males and 6 females, with a mean
age of 63 ± 12 years) and 36 had UCPPE (25 males and 11 fe-
males, with a mean age of 64 ± 13 years) (Table 1).
The median sTREM-1 levels in pleural ﬂuid were signiﬁ-
cantly higher in the bacterial PPE (688 ± 398 pg/mL) than
in the non-bacterial PPE (45 ± 79 pg/mL). Others, LDH, glu-
cose levels and TLC of pleural ﬂuid also demonstrated signif-
icant differences among the two groups, but pleural protein
level did not (Table 2).
The cut-off value of pleural ﬂuid sTREM-1 for the diagno-
sis of bacterial PPE (from the ROC curve; AUC= 0.92) was
130 pg/mL. This corresponded to 93% sensitivity and 92%
speciﬁcity, while it was 7.237 for pleural ﬂuid pH with 91%
sensitivity and 96% speciﬁcity and 640 mg/L. For pleural ﬂuid
glucose with 92% sensitivity and 86% speciﬁcity and 800 IU/L
for pleural ﬂuid LDH with 81% sensitivity and 90% speciﬁcity
(Table 3).
Discussion
The differentiation between non purulent complicated para-
pneumonic effusions, which require chest tube drainage, and
uncomplicated parapneumonic effusions, which respond to
antibiotic therapy alone, is sometimes difﬁcult because bio-
chemical parameters used are often nonspeciﬁc. Pleural ﬂuid
cultures are speciﬁc, but results may take days. A rapid micro-
biologic tool is the Gram stain, but its sensitivity is low,
approximately 50% [1].plicated parapneumonic effusions.
UCPPE (n= 36) P value
64 ± 13 P> .05
25 (69.4%) P> .05
11 (30.6%) P> .05
9 (25%) P> .05
1 P< .05
6 P> .05
2 P> .05
Table 2 Laboratory characteristics of pleural ﬂuid of the patients with complicated and uncomplicated parapneumonic effusions.
CPPE (n= 22) UCPPE (n= 36) P value
sTREM-1 (pg/mL) 688 ± 398 45 ± 79 P< .05
Protein (mg/dL) 2.8 (2.1–3.8) 2.6 (1.8–3.2) P> .05
Glucose (mg/dL) 89.6 (20.1–168.7) 170.3 (97.4–212.61) P< .05
LDH (IU/L) 353.2 (222–1023.3) 232 (140–501.3) P< .05
pH 6.79 (6.36–7.00) 7.40 (7.35–7.42) P< .05
TLC 13.24 (4.2–34.5) 7.6 (3.1–11.1) P< .05
Table 3 Accuracy of biomarkers for identiﬁcation of complicated parapneumonic effusions.
Cut-oﬀ value Sensitivity, % (95% CI) Speciﬁcity, % (95% CI AUC (95% CI)
LDH 800 IU/L 81 (64–94) 90 (67–99) 0.90 (0.81–0.99)
pH 7.237 91 (72–97) 96 (76–100) 0.92 (0.85–1.00)
Glucose 640 mg/L 92 (74–99) s 86 (62–97) 0.91 (0.76–1.00)
sTREM-1 130 pg/mL 93 (75–96) 92 (68–98) 0.92 (0.77–1.00)
AUC, area under the curve; CI, conﬁdence interval.
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uncomplicated when pleural pH is >7.2 and pleural glucose
is >60 mg/dL, since they resolve following antibiotic therapy,
whereas empyema and complicated parapneumonic effusions
require early drainage with or without instillation of local ﬁbri-
nolytic agents to prevent the development of pleural complica-
tions [9].
The detection of frank pus or Gram-positive ﬂuid or culture
dictates the need for placement of a chest tube drainage, but
management is not as clear-cut when ﬂuid is non purulent,
and Gram stain and culture are negative. A number of classi-
ﬁcations have been proposed to differentiate bacterial effu-
sions that require pleural drainage from those that resolve
with antibiotic therapy alone [10]. In 1995 Heffner et al. [11]
established that a pleural pH of 7.2 was the most useful marker
for draining parapneumonic pleural effusions, but later they
suggested that pleural pH < 7.1 and pleural glucose
<40 mg/dL or LDH >1000 are better criteria to determine
drainage of these effusions. Sahn [12] also recommended drain-
age when pleural ﬂuid pH is <7.1. The classiﬁcation of Light
[9] recommended drainage of effusions with pleural pH < 7.2
or glucose <40 mg/dL; however, since 1995 drainage is recom-
mended when pleural pH or pleural glucose is <7 or <40 mg/
dL, respectively. Borderline complicated parapneumonic pleu-
ral effusions with pleural pH between 7 and 7.2 should be man-
aged with daily therapeutic thoracentesis, and chest tubes
should be used if pleural pH falls <7 or if glucose falls
<40 mg/dL [5].
Despite these classiﬁcation systems, the diagnosis of com-
plicated pyogenic bacterial pleural effusions with classic mark-
ers is still delayed in some patients [5,6]. Thus, it would be
beneﬁcial to ﬁnd a marker, which, when associated with classic
pleural ﬂuid biochemical analysis, would help in the early iden-
tiﬁcation of pyogenic bacterial effusions so that pleural drain-
age could be quickly initiated to prevent the development of
local complications. sTREM-1 is a diagnostic marker for sep-
sis and inﬂammation. It has been described as a diagnostic
marker with a high accuracy and sensitivity in detecting micro-
bial infections as underlying disease in critically ill patients [6].The levels of sTREM-1 have previously been investigated in
plasma, bronchoalveolar lavage ﬂuid and exhaled breath [13].
Few studies have investigated the clinical signiﬁcance of
sTREM-1 in pleural effusions and found that patients with
complicated PPE or empyema exhibited the highest pleural
ﬂuid concentrations of this biomarker. However, there were
discrepancies regarding its discriminative properties as well
as its optimal cut-off point [14].
So this study was done to assess the usefulness of sTREM-1
for the identiﬁcation of complicated PPE that requires drain-
age. When complicated and uncomplicated parapneumonic
effusions were compared, sTREM-1 levels were signiﬁcantly
higher in complicated parapneumonic effusions Table 2 this re-
sult agrees with the result of previous studies.
This study demonstrated that sTREM-1 cut-off value of
130 pg/mL had a sensitivity of 93% and a speciﬁcity of 95
% for identiﬁcation of complicated PPE that requires drainage
(Table 3). Previous studies have evaluated the use of sTREM-1
for the same purpose. Bishara et al. [15] reported that a cut-off
value of 114 pg/mL for pleural sTREM-1 achieved a sensitivity
of 94% and a speciﬁcity of 93% (AUC 0.966) in differentiating
17 patients with empyema from 72 pleural effusions of other
aetiologies. Furthermore, Chan et al. reported that a
sTREM-1 at a cut-off value of 374 pg/mL yielded a sensitivity
of 93.8%, a speciﬁcity of 90.9% and an AUC of 0.93 in dis-
criminating bacterial pleural infection (n= 22) from tubercu-
lous pleuritis (n= 16) [13]. In another study sTREM-1 cut-
off value of 768.1 pg/mL had a sensitivity of 86%, speciﬁcity
of 93% and AUC of 0.93 in differentiating 23 bacterial effu-
sions (including 17 empyema) from 88 effusions with other
aetiologies [16]. The differences in representation of empyemas
and the lack of standardization of the ELISA technique in
these studies may explain the discrepancies in sTREM-1 con-
centrations and its cut-off points.
In conclusion
Combination of classical criteria with pleural ﬂuid sTREM-1
could be useful in discrimination between nonpurulent compli-
Diagnostic utility of soluble triggering receptor expression 597cated and non complicated parapneumonic pleural effusions
and for early recommendation of pleural drainage in patients
with complicated parapneumonic effusions which may affect
disease outcome.
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